I help life sciences organizations improve their strategy, productivity, and impact.
Program Management Office
Goal is better results from your projects, without additional bureaucracy.
We set-up and manage PMOs to oversee your projects and initiatives, with an emphasis on outcomes not imputs.
Goal is long-term culture and performance improvement across your lines of business.
We run impact assessments, secure stakeholder buy-in, and implement change programs.
Goal is maximizing the value that your transactions aim to create.
We plan and integrate your acquisitions with an eye to realizing full synergy potential in a collaborative manner.
Goal is more effective negotiation strategies that maximize value-capture.
We advise on negotiations with suppliers, licensees, investors, board members, agencies, strategic partners, M&A targets.
Goal is to improve your key internal and external relationships.
We work with you to understand the roots of your relationship challenges, then help you realize their full potential.
Goal is to help teams get the most out of their important conversations.
We can facilitate planning, brainstorming, or strategy sessions that are inspiring, impartial, and decision-oriented.
Supported product strategy for a leading mRNA biotech, playing Chief of Staff across multiple functions and framing strategic trade-offs for management.
Revamped the business model and investor strategy for a genetics startup so it could focus on a significantly larger target market in a more cost-effective way.
Set-up and led a PMO for the US manufacturing plant of a global pharma company, improving plant governance and project accountability.
Built a staffing model for a global biotech in order to more effectively plan cross-functional staff involvement in high-priority clinical trials.
Jeffrey Hugh Christiansen
Jeff is a former Bain & Company consultant with a passion for advising on negotiations, and managing complex projects, in the life sciences. He founded ValCap Life Sciences in 2019.
Over the past 16 years, he has worked across four continents in a range of capacities, from private equity investing and capacity-building to project management and large-scale change programs. Since 2006, he has taught courses, led workshops, and advised on negotiations.
His negotiation advisory is based on ideas developed at the Program on Negotiation - a consortium of Harvard, MIT, and Tufts and a pioneer in interdisciplinary thinking on negotiation strategy since 1983 - as well as his broad industry and geographic experience.
During the Covid-19 pandemic, he worked with world-shaping organizations to support the development and commercialization of the mRNA vaccine, along the way developing an even deeper appreciation for how innovation -- and effective execution -- can deliver amazing results.
He is also an investor in -- and an occasional advisor to -- select early-stage life sciences companies.
Jeff studied at Washington University in St. Louis, Georgetown, and Oxford, and currently resides in New York City.